The global IVD market is valued at approximately $113 billion in 2026 and is projected to reach $157 billion by 2030 at a CAGR of 7.6%, driven by rising chronic disease prevalence, aging populations, expanding molecular diagnostics, and the accelerating shift to point-of-care testing. IVD tests now influence approximately 70% of all clinical decisions. Roche, Abbott, Danaher, Siemens Healthineers, bioMérieux, Sysmex, QuidelOrtho, Hologic, Bio-Rad, and DiaSorin collectively account for over 60% of global IVD revenues and are deploying AI, automation, and menu expansion to extend their competitive positions.
92 countries — 38 European, 18 Asia-Pacific, 22 Latin American, 11 Middle Eastern, and 3 North American countries.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Global IVD Market Size and Forecast 2025-2030 by Segment, Technology, and Region
• High-Growth Segments — Molecular Diagnostics, Point-of-Care, Liquid Biopsy, and AI-Enabled Diagnostics
• Business Strategies of the World's 10 Leading IVD Suppliers
• Competitive Positioning, Market Share, and Portfolio Analysis
• Technology Investment Priorities — NGS, AI, Digital Pathology, and Automation
• Regional Dynamics — North America, Europe, Asia-Pacific, Latin America, and Middle East
• M&A Activity and Strategic Alliances 2023-2025
• Investment and Partnership Opportunities
• Strategic Recommendations for Market Entry and Expansion
'
Table of Contents
1. Executive Summary
- Key findings and strategic implications
- Highest-priority growth opportunities by segment and technology
- Competitive landscape summary
- Regional growth outlook
- Strategic recommendations
2. Market Overview
- Market definition, scope and segmentation
- Market size and growth 2020-2030
- Key demand drivers and restraints
- Regulatory environment — EU IVDR, FDA LDT Rule, and global frameworks
3. High-Growth Opportunity Analysis
- 3.1 AI and Laboratory Automation
- 3.2 Point-of-Care Testing
- 3.3 Oncology and Liquid Biopsy
- 3.4 Emerging Markets Expansion
- 3.5 Immunoassay and Clinical Chemistry Consolidation
- 3.6 Hematology, Coagulation, and Urinalysis
- 3.7 Regulatory Transformation
- Each section covers: market size, growth and forecast / leading suppliers and competitive landscape / key opportunities and strategic entry points
4. Competitive Landscape Overview
- Recent M&A, partnerships, joint ventures and strategic alliances
- Emerging competitive threats from domestic Asian suppliers
5. Regional Market Analysis
- 5.1 North America (U.S., Canada, Mexico)
- 5.2 Europe (38 countries)
- 5.3 Asia-Pacific (18 countries)
- 5.4 Latin America (22 countries)
- 5.5 Middle East (11 countries)
- 5.6 Africa and Rest of World
6. Company Profiles — The World’s Leading IVD Suppliers
- 6.1 Abbott Diagnostics
- 6.2 Bio-Rad Laboratories
- 6.3 bioMérieux
- 6.4 Danaher (Beckman Coulter, Cepheid, Radiometer)
- 6.5 DiaSorin
- 6.6 Hologic
- 6.7 QuidelOrtho
- 6.8 Roche Diagnostics
- 6.9 Siemens Healthineers
- 6.10 Sysmex
- For each company: strategic directions / financial performance / market share and competitive positioning / key platforms and programs / strategic priorities and growth strategies
7. Strategic Conclusions and Recommendations
- Highest-priority growth opportunities by segment and region
- Market entry and expansion strategies
- M&A, partnership and investment priorities
8. Appendix
- Research methodology
- Abbreviations and definitions
- List of tables and figures
List of Tables
Table 1. Global IVD Market Size and Growth 2020-2030 by Segment
Table 2. Market Segmentation by Technology 2025
Table 3. Market Segmentation by End-User 2025
Table 4. Key Demand Drivers and Impact Assessment 2025-2030
Table 5. AI and Laboratory Automation — Platform Comparison and Leading Suppliers 2025
Table 6. Point-of-Care Testing — Application Landscape and Leading Suppliers 2025
Table 7. Oncology and Liquid Biopsy — Application Landscape and Leading Suppliers 2025
Table 8. Immunoassay and Clinical Chemistry — Platform Competition 2025
Table 9. Hematology, Coagulation, and Urinalysis — Leading Suppliers 2025
Table 10. Recent M&A Transactions 2023-2025
Table 11. North America and Europe IVD Market Analysis 2025-2030
Table 12. Asia-Pacific IVD Market Analysis 2025-2030
Table 13. Latin America and Middle East IVD Market Analysis 2025-2030
Table 14. World’s Leading Suppliers Revenue Comparison 2023-2025
Table 15. World’s Leading Suppliers R&D Investment Comparison 2023-2025
Table 16. World’s Leading Suppliers Geographic Revenue Distribution 2025
Table 17. World’s Leading Suppliers M&A Activity Summary 2023-2025
Table 18. World’s Leading Suppliers Strategic Priorities 2025-2030
Abbott Diagnostics
Bio-Rad Laboratories
bioMérieux
Danaher (Beckman Coulter, Cepheid, Radiometer)
DiaSorin
Hologic
QuidelOrtho
Roche Diagnostics
Siemens Healthineers
Sysmex
